1. A promising inactivated whole-virion SARS-CoV-2 vaccine. Issue 1 (January 2021) Authors: Isakova-Sivak, Irina; Rudenko, Larisa Journal: Lancet infectious diseases Issue: Volume 21:Issue 1(2021) Page Start: 2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine. (2nd November 2018) Authors: Korenkov, Daniil; Isakova-Sivak, Irina; Rudenko, Larisa Journal: Expert review of vaccines Issue: Volume 17:Number 11(2018) Page Start: 977 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cold-adapted influenza viruses as a promising platform for viral-vector vaccines. (2nd October 2016) Authors: Isakova-Sivak, Irina; Tretiak, Tatiana; Rudenko, Larisa Journal: Expert review of vaccines Issue: Volume 15:Number 10(2016) Page Start: 1241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine. Issue 1 (1st January 2015) Authors: Carter, Donald M.; Bloom, Chalise E.; Kirchenbaum, Greg A.; Tsvetnitsky, Vadim; Isakova-Sivak, Irina; Rudenko, Larisa; Ross, Ted M. Journal: Vaccine Issue: Volume 33:Issue 1(2015) Page Start: 108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine. Issue 1 (1st January 2015) Authors: Carter, Donald M.; Bloom, Chalise E.; Kirchenbaum, Greg A.; Tsvetnitsky, Vadim; Isakova-Sivak, Irina; Rudenko, Larisa; Ross, Ted M. Journal: Vaccine Issue: Volume 33:Issue 1(2015) Page Start: 108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cross-protective potential of a MF59-adjuvanted quadrivalent influenza vaccine in older adults. Issue 7 (July 2021) Authors: Isakova-Sivak, Irina; Rudenko, Larisa Journal: Lancet infectious diseases Issue: Volume 21:Issue 7(2021) Page Start: 900 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories. Issue 45 (26th October 2016) Authors: Rudenko, Larisa; Yeolekar, Leena; Kiseleva, Irina; Isakova-Sivak, Irina Journal: Vaccine Issue: Volume 34:Issue 45(2016) Page Start: 5436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories. Issue 45 (26th October 2016) Authors: Rudenko, Larisa; Yeolekar, Leena; Kiseleva, Irina; Isakova-Sivak, Irina Journal: Vaccine Issue: Volume 34:Issue 45(2016) Page Start: 5436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial. Issue 3 (March 2016) Authors: Rudenko, Larisa; Isakova-Sivak, Irina; Naykhin, Anatoly; Kiseleva, Irina; Stukova, Marina; Erofeeva, Mariana; Korenkov, Daniil; Matyushenko, Victoria; Sparrow, Erin; Kieny, Marie-Paule Journal: Lancet infectious diseases Issue: Volume 16:Issue 3(2016:Mar.) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?. (January 2014) Authors: Rudenko, Larisa; Isakova-Sivak, Irina; Rekstin, Andrey Journal: Expert review of vaccines Issue: Volume 13:Number 1(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗